Distributed Manufacturing Can Stabilize Biopharma Production Over the past two decades, the supply chains of drug manufacturing companies have become longer, more intricate, and increasingly fragmented. In fact, supply chain complexity was identified as a root cause of drug shortages in a report released in 2019 and updated last year by the interagency Drug Shortage Task Force, which is run by the FDA. [Andrew Brookes / Cultura / Getty Images] 3M describes how biopharma manufacturers can enhance supply chain security in the age of COVID-19 and beyond May 3, 2021 Over the past two decades, the supply chains of drug manufacturing companies have become longer, more intricate, and increasingly fragmented. In fact, supply chain complexity was identified as a root cause of drug shortages in a report released in 2019 and updated last year by the interagency Drug Shortage Task Force, which is run by the FDA. [Andrew Brookes / Cultura / Getty Images]